Assertio Therapeutics
ASRT
$1.06
Share price
2.91%
Change (1 day)
-82.76%
Change (1 year)
Categories
P/S ratio for Assertio Therapeutics (ASRT)
P/S ratio as of May 2024 (TTM): 0.6443
According to Assertio Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.644286. At the end of 2023 the company had a P/S ratio of 0.6661.
P/S ratio history for Assertio Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.6661 | -49.89% |
| 2022 | 1.33 | 51.65% |
| 2021 | 0.8765 | 142.94% |
| 2020 | 0.3608 | -18.11% |
| 2019 | 0.4406 | -40.72% |
| 2018 | 0.7432 | -44.22% |
| 2017 | 1.33 | -45.26% |
| 2016 | 2.43 | -24.3% |
| 2015 | 3.22 | 31.41% |
| 2014 | 2.45 | -45.89% |
| 2013 | 4.52 | 17.68% |
| 2012 | 3.84 | 78.07% |
| 2011 | 2.16 | -48.25% |
| 2010 | 4.17 | 37.67% |
| 2009 | 3.03 | 25.29% |
| 2008 | 2.42 | 1.62% |
| 2007 | 2.38 | -84.33% |
| 2006 | 15.2 | -72.8% |
| 2005 | 55.8 | -90.63% |
| 2004 | 596 | 138.74% |
| 2003 | 250 | 1159.42% |
| 2002 | 19.8 | -8.5% |
| 2001 | 21.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | 62.87% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 14,256.76% | 🇺🇸 USA |